PARAG SAXENA
CIK 1015823 · Chief Executive Officer · last filed 2025-12-19
PARAG SAXENA is a Chief Executive Officer who has filed 9 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for RVPH, was dated Dec 19, 2025. Across all open-market trades the lifetime net is +$3.4M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
9
$3.43M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVPH | Director | — | $0.71 | — | $0 | 1 | 2025-12-19 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Director | — | $0.00 | — | $0 | 5 | 2024-12-12 |
| Eucrates Biomedical Acquisition Corp. (EUCRU) Delisted | Chief Executive Officer | 2,619,906 | $10.02 | $26.25M | $0 | 1 | 2020-11-27 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (TZACU) Delisted | Chairman of the Board | 1,924,250 | — | — | $3.43M | 2 | 2018-09-04 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-19 | RVPH | Grant (A) | — | $0 | EDGAR |
| 2024-12-12 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-14 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-14 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-10 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-16 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-27 | Eucrates Biomedical Acquisition Corp. (EUCRU) Delisted | Other (J) | −255,094 | $0 | EDGAR |
| 2018-09-04 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (TZACU) Delisted | Buy (P) | +33,000 | $330.0K | EDGAR |
| 2018-08-24 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (TZACU) Delisted | Buy (P) | +310,000 | $3.10M | EDGAR |